Publication | Closed Access
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic <scp>HCV</scp> genotype <scp>IV</scp> infected patients
60
Citations
14
References
2016
Year
Sofosbuvir/Simeprevir combination is an effective and well tolerated regimen for patients with chronic HCV genotype IV.
| Year | Citations | |
|---|---|---|
Page 1
Page 1